Completion of Phase Iii Clinical Trial, Option and Mutual Release Agreement Sample Contracts

COMPLETION OF PHASE III CLINICAL TRIAL, OPTION AND MUTUAL RELEASE AGREEMENT

Completion of Phase Iii Clinical Trial, Option and Mutual Release Agreement • May 6th, 2015 • Hyperion Therapeutics Inc • Pharmaceutical preparations • Delaware

• Contract Type
  Completion of Phase Iii Clinical Trial, Option and Mutual Release Agreement
• Filed
  May 6th, 2015
• Company
  Hyperion Therapeutics Inc
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This SHARE PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of , 201[5] (the “Agreement Date”), by and among Hyperion Therapeutics, Inc., a Delaware corporation (“Parent”), Hyperion Therapeutics Israel Holding Corp. Ltd. an Israeli company and a wholly-owned subsidiary of Parent (“Company Shareholder”), Clal Biotechnology Industries Ltd. (the “Purchaser”), and Andromeda Biotech Ltd., an Israeli company (the “Company”).